INQUISAL   20936
INSTITUTO DE QUIMICA DE SAN LUIS "DR. ROBERTO ANTONIO OLSINA"
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Determination of estrogenic endocrine disruptor: ethinylestradiol, using modified magnetic nanoparticles
Autor/es:
MARTÍNEZ NA; FERNÁNDEZ-BALDO MA; BERTOLINO FA; SANZ MI; MESSINA GA; RABA J
Reunión:
Congreso; 1ª Reunión Internacional de Ciencias Farmacéuticas, Córdoba, Argentina, 24 y 25 de Junio de 2010.; 2010
Resumen:
<!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1610611985 1073750139 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-fareast-font-family:"Times New Roman"; mso-bidi-font-family:"Times New Roman"; mso-ansi-language:ES-AR;} span.apple-style-span {mso-style-name:apple-style-span; mso-style-unhide:no; font-family:"Times New Roman","serif"; mso-bidi-font-family:"Times New Roman";} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt; mso-ascii-font-family:Calibri; mso-hansi-font-family:Calibri;} .MsoPapDefault {mso-style-type:export-only;} @page Section1 {size:612.0pt 792.0pt; margin:72.0pt 72.0pt 72.0pt 72.0pt; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.Section1 {page:Section1;} --> Ethinylestradiol (EE2) is a synthetic estrogen female sex hormone which is used as a contraceptive therapy. The determination of synthetic estrogen has attracted much attention since these compounds were included in the endocrine disrupting chemicals (EDCs) and its able to cause the deleterious reproductive dysfunction of animals and humans (1). Due the problems mentioned previously, is important the determination of EE2 in water samples. Therefore we present a method that combined the use of magnetic nanoparticles (MNPs) modified with anti-EE2 antibodies and square-wave voltammetry (OSWV). The advance in experimental electrochemical techniques in the field of analysis of drugs is due to their simplicity, low cost and relatively short time of analysis when they are compared with the other techniques (2-7). In addition the use of MNPs also have attracted great interest for biological and clinical applications (8–11), and they are widely used as a new agent of preconcentration due to its features, between these: large surface area (12), strong magnetism, improve the adsorption capacity of analytes and avoid the time-consuming enrichment process of loading large volume samples through the rapid isolation of NPs with an adscititious magnet.